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ABSTRACT
Objective To conduct a comprehensive systematic review
and meta-analysis of studies assessing the effect of
alcohol consumption on multiple cardiovascular
outcomes.
Design Systematic review and meta-analysis.
Data sources A search of Medline (1950 through
September 2009) and Embase (1980 through September
2009) supplemented by manual searches of
bibliographies and conference proceedings.
Inclusion criteria Prospective cohort studies on the
association between alcohol consumption and overall
mortality from cardiovascular disease, incidence of and
mortality from coronary heart disease, and incidence of
and mortality from stroke.
Studies reviewed Of 4235 studies reviewed for eligibility,
quality, and data extraction, 84 were included in the final
analysis.
Results The pooled adjusted relative risks for alcohol
drinkersrelativetonon-drinkersinrandomeffectsmodels
for the outcomes of interest were 0.75 (95% confidence
interval0.70to 0.80)forcardiovascular diseasemortality
(21 studies), 0.71 (0.66 to 0.77) for incident coronary
heart disease (29 studies), 0.75 (0.68 to 0.81) for
coronary heart disease mortality (31 studies), 0.98 (0.91
to1.06)forincidentstroke(17studies),and1.06(0.91to
1.23) for stroke mortality (10 studies). Dose-response
analysis revealed that the lowest risk of coronary heart
disease mortality occurred with 1–2 drinks a day, but for
stroke mortality it occurred with ≤1 drink per day.
Secondary analysis of mortality from all causes showed
lower risk for drinkers compared with non-drinkers
(relative risk 0.87 (0.83 to 0.92)).
Conclusions Light to moderate alcohol consumption is
associated with a reduced risk of multiple cardiovascular
outcomes.
INTRODUCTION
Possible cardioprotective effects of alcohol consump-
tion seen in observational studies continue to be hotly
debatedinthemedicalliteratureandpopularmedia.In
the absence of clinical trials, clinicians must interpret
these data when answering patients’ questions about
taking alcohol to reduce their risk of cardiovascular
disease. Systematic reviews and meta-analyses have
addressed the association of alcohol consumption
with cardiovascular disease outcomes
1-8 but have not
uniformly addressed associations between alcohol
use and mortality from cardiovascular disease, as well
astheincidenceandmortalityfromcoronaryheartdis-
ease and stroke. Additionally, further studies have
been published since 2006, when the most recent
reviews appeared. The continuing debate on this sub-
jectwarrantsanin depthreassessment ofthe evidence.
Inthispaper,wesynthesiseresultsfromlongitudinal
cohort studies comparing alcohol drinkers with non-
drinkers for the outcomes of overall mortality from
cardiovascular disease, incident coronary heart dis-
ease, mortality from coronary heart disease, incident
stroke, and mortality from stroke. Because of the
many biological effects of alcohol consumption, we
also examine the association of alcohol with mortality
from all causes when this is reported in studies. We
conducted meta-analyses for each of these outcomes
and a sensitivity analysis with lifetime abstainers as
thereferencecategorytoaccountfortheheterogeneity
within the reference group of non-drinkers. We also
examined the effect of confounding on the strength of
observed associations. In our companion paper,
110 we
link these cardiovascular outcomes with experimental
trials of alcohol consumption on candidate causal
molecular markers.
METHODS
Data sources and searches
We performed a systematic review and meta-analysis
following a predetermined protocol in accordance
withtheMeta-analysisofObservationalStudiesinEpi-
demiology (MOOSE) reporting guidelines.
9 We iden-
tified all potentially relevant articles regardless of
languagebysearchingMedline(1950throughSeptem-
ber 2009) and Embase (1980 through September
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phiesofidentifiedarticlesandreviewarticles,aswellas
reviewing conference proceedings from three major
scientific meetings (American Heart Association,
American College of Cardiology, and European
Heart Congress) between 2007 and 2009. Experts in
the field were contacted regarding missed, ongoing,
or unpublished studies.
To search electronic databases, we used the strategy
recommended for systematic reviews of observational
studies.
10 We specified three comprehensive search
themes:
 To identify relevant terms related to the
exposure of interest (theme 1), the first Boolean
search used the term “or” to explode (search by
subject heading) and map (search by keyword)
the medical subject headings “ethanol” or
“alcohol” or “alcoholic beverages” or “drinking
behaviour” or “alcohol drinking” or text words
“drink$” or “liquor$” or “ethanol intake” or
“alcohol$ drink$” or “ethanol drink$”
 To identify relevant outcomes (theme 2), a
second Boolean search was performed using the
term “or” to explode and map the medical
subject headings “stroke” or “cardiovascular
diseases” or “myocardial infarction” or
“myocardial ischemia” or “coronary artery
disease” or “heart infarction” or text words
“cva$” or “infarct$” or “ischem$” or “cvd” or
“ami” or “ihd” or “cad”
 To identify relevant study designs (theme 3), a
final Boolean search using the term “or” to
explode and map the medical subject headings
“cohort studies” or “follow-up studies” or
“incidence” or “prognosis” or “early diagnosis”
or “survival analysis” or text words “course” or
predict$” or “prognos$” was performed.
These three comprehensive search themes were
then combined using the Boolean operator “and” in
varying combinations.
Study selection
Two individuals (SEB and PER) independently
reviewed all identified abstracts for eligibility. All
abstracts reporting on the association between alcohol
intake and cardiovasculardisease eventswere selected
forfulltextreview.Thisstagewasintentionallyliberal.
We discarded only those abstracts that clearly did not
meet the aforementioned criteria. The inter-rater
agreement for this review was high (κ=0.86 (95% con-
fidence interval 0.80 to 0.91)). Disagreements were
resolved by consensus.
Thesamereviewersperformedthefulltextreviewof
articles that met the inclusion criteria and articles with
uncertain eligibility. Articles were retained if they met
the inclusion criteria for study design (prospective
cohort design), study population (adults ≥18 years old
without pre-existing cardiovascular disease), exposure
(current alcohol use with a comparison group of non-
drinkers),andoutcome(overallcardiovasculardisease
mortality or atherothrombotic conditions, specifically
incidentcoronaryheartdisease,coronaryheartdisease
mortality, incident stroke, or stroke mortality). Both
published and unpublished studies were eligible for
inclusion. Authors were contacted if the risk profile of
the cohort was unclear.
Data extraction and quality assessment
The primary exposure variable was the presence of
active alcohol drinking at baseline compared with a
reference group of non-drinkers. Because of the hetero-
geneity of this reference group, we identified the subset
ofstudiesusinglifetimeabstainersasthereferencegroup
andstudiesthatdistinguishedformerdrinkersfromnon-
drinkers.Wheneveravailable,weextractedinformation
onamountofalcoholconsumed, usinggramsofalcohol
per day as the common unit of measure. When a study
did not specifically report the grams of alcohol per unit,
we used 12.5 g/drink for analysis.
11 We standardised
p o r t i o n sa sa1 2o z( 3 5 5m l )b o t t l eo rc a no fb e e r ,a5o z
(148ml)glassofwine,and1.5oz(44ml)glassof80proof
(40%alcohol)distilledspirits.Volumeofintakewascate-
gorised as <2.5 g/day (<0.5 drink), 2.5–14.9 g/day
(about0.5–1d r i n k ) ,1 5 –29.9 g/day (about 1–2.5 drinks),
30–60 g/day (about 2.5–5 drinks), and >60 g/day
(≥5 drinks).
The outcome variables of interest were defined as
the presence or absence of death from cardiovascular
disease (that is, fatal cardiovascular or stroke events),
incident coronary heart disease (fatal or non-fatal inci-
dent myocardial infarction, angina, ischaemic heart
disease, or coronary revascularisation), death from
coronary heart disease (fatal myocardial infarction or
ischaemic heart disease), incident stroke (ischaemic or
haemorrhagicevents),ordeathfromstroke.Asecond-
ary analysis was performed within these selected
Citations identified from electronic searches (n=4235)
Potentially relevant articles retrieved for further scrutiny (full text, if available) (n=230)
Eligible full text articles (n=131)
Studies included in meta-analyses (n=84)
Incident coronary
heart disease
events (n=29)
Incident stroke
events (n=17)
Stroke mortality
(n=10)
Coronary
heart disease
mortality (n=31)
Cardiovascular
disease
mortality (n=21)
Citations excluded (studies did not report on alcohol intake and
cardiovascular disease outcomes, or did not contain original data) (n=4005)
Articles excluded (n=47):
  Duplicate data (n=32)
  Inappropriate outcomes (including cancer, congestive heart failure,
    arrhythmias, composite end points) (n=15)
Articles excluded (inappropriate study population,
outcomes, or alcohol comparator) (n=101)
Relevant articles identified through bibliographic search (n=2)
Fig 1 | Details of study selection for review
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Study Cohort designation
No of
subjects Country Men (%)
Age
range
(years)
Study
follow-up
(years) Outcomes measured
Albert et al 1999
22 Physicians’ Health Study 21 537 USA 100 40–84 12 CHD mortality
Bazzano et al 2007
23
China National Hypertension Survey
Epidemiology Follow-up Study
64 338 China 100 ≥40 8 Incident stroke and stroke mortality
Bazzano et al 2009
24 64 597 China 100 ≥40 8 IncidentCHD;CVDandCHDmortality
Berberian et al 1994
25 Zoetermeer Cohort 1620 Netherlands 46.9 >20 10 CVD mortality
Berger et al 1999
26 Physicians’ Health Study 22 071 USA 100 40–84 12.2 Incident stroke
Blackwelderetal1980
27 Honolulu Heart Program 7888 USA 100 Not
reported
8 CHD and stroke mortality
Boffetta et al 1990
28 American Cancer Society Prospective Study 276 802 USA 100 40–59 12 CHD mortality
Burke et al 2007
29 Western Australian Aboriginal cohort 514 Australia 50.2 15–88 11.6 Incident CHD
Camargo et al 1997
30 Physicians’ Health Study 22 071 USA 100 40–84 11 Incident CHD
Chiuve et al 2008
31 Nurses’ Health Study 71 243 USA 0 34–59 20 Incident stroke
Health Professionals Follow-up Study 43 685 USA 100 40–75 18 Incident stroke
Colditz et al 1985
32 Massachusetts cohort 1184 USA 38 ≥66 4.75 CHD mortality
Cullen et al 1993
33 Brusselton, Western Australian cohort 2171 Australia 50 ≥40 23 CHD and CVD mortality
Deev et al 1998
34 US-Russian Lipid Research Clinics
Prevalence Study
4011 USA 46.6 40–69 13
CVD mortality
4153 Russia 46.7 40–69 13
Diem et al 2003
35 Multinational Study of Vascular Disease in Diabetes 287 Switzerland 56.4 ≥35 12.6 CHD mortality
Djousse et al 2002
36 Framingham Study 9171 USA 42.2 ≥50 10 Incident stroke
Djousse et al 2009
37 Women’s Health Study 26 399 USA 0 ≥45 12 CVD mortality
Doll et al 2005
38 British Physician Cohort 12 325 UK 100 48–78 23 CHD mortality
Donahue et al 1986
39 Honolulu Heart Program 8006 USA 100 45–69 12 Incident stroke
Ebbert et al 2005
40 Iowa Women’s Health Study 30 518 USA 0 55–69 14 CHD mortality
Ebrahim et al 2008
41 Women’s Heart and Health Study 2717 UK 0 60–79 4.7
Incident CHD
Caerphilly Study 1291 UK 100 47–67 20
Elkind et al 2006
42 Northern Manhattan Study 3176 USA 37.2 ≥40 5.9 Incident stroke
Friedman et al 1986
43 Framingham Study 4745 USA 44.4 30–59 24 CHD mortality
Fuchs et al 1995
44 Nurses’ Health Study 85 709 USA 0 34–59 12 CVD mortality
Fuchs et al 2004
45 Atherosclerosis Risk in Communities Study 14 506 USA 43.3 45–64 9.8 Incident CHD
Garfinkel et al 1988
46 American Cancer Society Prospective Study 581 321 USA 0 >30 12 CHD mortality
Garg et al 1992
47 National Health and Nutrition Examination Study 3718 USA 0 45–74 13 CHD mortality
Gaziano et al 2000
48 Physicians’ Health Study 89 299 USA 100 40–84 5.5 CVD and stroke mortality
Gordon et al 1983
49 Framingham Study 4625 USA 43.8 29–62 22 Incident CHD
Gordon et al 1985
50 Albany Study 1755 USA 100 38–55 18 Incident CHD
Gronbaek et al 1995
51 Copenhagen City Heart Study 13 285 Denmark 45.5 30–79 12 CVD mortality
Gun et al 2006
52 Employees of Australian Institute of Petroleum
member companies
16 547 Australia 100 NR 20 CHD mortality
Hammar et al 1997
53 Swedish Twin Register 1900 Sweden 67.4 30–74 NR Incident CHD
Hansagi et al 1995
54 Swedish Twin Register 15 077 Sweden 47 ≥42 20 Stroke mortality
Harriss et al 2007
55 Melbourne Collaborative Cohort Study 38 200 Australia 39.7 27–75 11.4 CHD and CVD mortality
Hart et al 2008
56 Midspan Collaborative Cohort Study 6000 Scotland 100 35–64 35 CHD and stroke mortality
Hein et al 1996
57 Copenhagen Male Study 2826 Denmark 100 53–74 6 Incident CHD
Ikehara et al 2009
58 JapanPublicHealthCenter-BasedProspectiveStudy 19 356 Japan 100 40–69 9.9 Incident CHD and stroke
Iso et al 1995
59 Rural Japanese cohorts 2890 Japan 100 40–69 10.5 Incident CHD and stroke
Jakovljevic et al 2004
60 Institute for Chronic Diseases and Gerontology 286 Serbia and
Montenegro
50.7 30–60 20 Stroke mortality
Jamrozik et al 2000
61 Perth Community Stroke Study 931 Australia 48 >18 4 CVD mortality
Jousilahti et al 2000
62 Finnish Cohort 14 874 Finland 48.2 25–64 12 Incident stroke
Kitamura et al 1998
63 Japanese Male Employees 8476 Japan 100 40–59 8.8 Incident CHD
Kittner et al 1983
64 Puerto Rico Heart Health Program 9150 Puerto Rico 100 35–79 12 Incident CHD and CHD mortality
Kivela et al 1989
65 Two Finnishcohortsfrom the SevenCountriesStudy 1112 Finland 100 55–74 10 CVD mortality
Kiyohara et al 1995
66 Hisayama Study 1621 Japan 43.6 ≥40 26 Incident stroke
Klatsky et al 1990
67
Kaiser Permanente Medical Care Program Cohort
123 840 USA 40.5 <30–>70 7 CVD mortality
Klatsky et al 1997
68 128 934 USA 44 <30–>70 NR Incident CHD
Klatsky et al 2002
69 128 934 USA 44 <30–>70 18 Incident stroke
Knoops et al 2004
70 Healthy Ageing: A Longitudinal Study in Europe 2339 11 European
countries
64.4 70–90 10 CHD and CVD mortality
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consumption and the risk of death from all causes.
Both reviewers independently extracted data from
all studies fulfilling the inclusion criteria, and any dis-
agreement was resolved by consensus. We extracted
the data elements of cohort name, sample size, and
population demographics (country, percentage male,
meanageoragerange).Wealsoextractedinformation
forkey indicatorsof studyqualityin observationalstu-
dies proposed by Egger et al
10 and Laupacis et al.
12
Specifically, we evaluated the effect on each outcome
of the number of potential confounding variables and
the number of years participants were followed.
Data synthesis and analysis
The relative risk was used as the common measure of
associationacrossstudies.Hazardratiosandincidence
densityratiosweredirectlyconsideredasrelativerisks.
Where necessary, odds ratios were transformed into
relative risks with this formula:
Relative risk=odds ratio/[(1–Po)+(Po×odds ratio)], in
which Po is the incidence of the outcome of interest
in the non-exposed group.
13
The standard error of the resulting converted rela-
tive risk was then determined with this formula:
SElog(relative risk)=SElog(odds ratio)×log(relative
risk)/log(odds ratio).
Study Cohort designation
No of
subjects Country Men (%)
Age
range
(years)
Study
follow-up
(years) Outcomes measured
Kono et al 1986
71 Japanese Male Physician Cohort 5135 Japan 100 NR 19 CHD, CVD and stroke mortality
Leppala et al 1999
72 Alpha-Tocopherol, Beta-CaroteneCancerPrevention
cohort
26 556 Finland 100 50–69 6.1 Incident stroke
Lin et al 2005
73 Japan Collaborative Cohort Study for Evaluation
of Cancer Risk
110 792 Japan 41.9 40–79 11 CVD mortality
Manttari et al 1997
74 Helsinki Heart Study 1924 Finland 100 40–55 5 Incident CHD
Marques-Vidal et al
2004
75
PRIME Study—France 7352 France 100 50–59 5
Incident CHD
PRIME Study—Northern Ireland 2398 Ireland 100 50–59 5
Maskarinec et al 1998
76 Multiethnic cohort (Hawaii) 27 678 USA 50.1 >30 NR CHD and stroke mortality
M u k a m a le ta l2 0 0 3
77 Health Professionals Follow-up Study 38 077 USA 100 40–75 12 Incident CHD and CHD mortality
M u k a m a le ta l2 0 0 5
78
Cardiovascular Health Study
4410 USA 36.1 ≥65 9.2 Incident stroke
M u k a m a le ta l2 0 0 6
79 4410 USA 38.7 ≥65 9.2 Incident CHD
Murray et al 2002
80 Manitoba Health Cohort 1154 Canada 50.2 18–64 8 Incident CHD
Murray et al 2005
81 Lung Health Study 3702 Canada 100 35–60 14 Incident CHD
Pedersen et al 2008
82 Copenhagen City Heart Study 11 914 Denmark 44.3 ≥20 20 CHD mortality
Rehm et al 1997
83 National Health and Nutrition Examination Study 6788 USA 43.6 40–75 14.6 Incident CHD and CHD mortality
Renaud et al 1999
84 Cohort from Centre de Medecine Preventive 36 250 France 100 40–60 12–18 CHD and CVD mortality
Salonen et al 1983
85 Two counties of eastern Finland 4063 Finland 100 30–59 7 Incident CHD
Sankai et al 2000
86 Six Japanese communities 12 372 Japan 40.2 40–69 9.4 Incident stroke
Scherr et al 1992
87 Established populations for Epidemiologic Studies
of the Elderly
6891 USA 36.9 >65 5 CVD mortality
Shaper et al 1987
88 British Regional Heart Study 6103 UK 100 40–59 6.2 Incident CHD
Simons et al 1996
89 Dubbo Cohort of New South Wales 2805 Australia 44.1 ≥60 6.4 Incident CHD
Solomon et al 2000
90 Nurses’ Health Study 121 700 USA 0 30–55 NR Incident CHD and CHD mortality
Suh et al 1992
91 Multiple Risk Factor Intervention Trial 11 688 USA 100 35–57 3.8 CHD mortality
Suhonen et al 1987
92 Social Insurance Institution’s Mobile Clinic Health
Survey
4532 Finland 100 40–64 5 CHD mortality
Thun et al 1997
93 Cancer Prevention Study II 489 626 USA 51.3 30–104 9 CHD, CVD and stroke mortality
Tolstrup et al 2006
94 Danish Cohort 53 500 Denmark 46.8 50–65 5.7 Incident CHD
Trevisan et al 2001
95 Risk Factors and Life Expectancy Study 8647 Italy 100 30–59 7 CHD and CVD mortality
Truelsen et al 1998
96 Copenhagen City Heart Study 13 329 Denmark 45.5 45–84 16 Incident stroke
Valmadrid et al 1999
97 Wisconsin Epidemiologic Study of Diabetic
Retinopathy
983 USA 45.2 NR 12.3 CHD mortality
Waskiewicz et al 2004
98 Pol-MONICA Programme 5452 Poland 49.3 35–64 NR CVD mortality
Wellmann et al 2004
99 MONICA Augsburg Cohort 2710 Germany 49.6 35–64 10 Incident CHD
Wilkins 2002
100 National Population Health Survey 6014 Canada 43.8 ≥40 4 Incident CHD
Woo et al 1990
101 Elderly Chinese Cohort 427 China 40 ≥60 2.5 Incident stroke
Xu et al 2007
102 Husbands from Shanghai Women’s Health Study 64 515 China 100 30–89 4.6 CHD and CVD mortality
Yang et al 1999
103 South Bay Heart Watch Cohort 1196 USA 89 ≥45 3.4 Incident CHD
Yuan et al 1997
104 Four communities in Shanghai 18 244 China 100 45–64 6.7 CHD and stroke mortality
Zhang et al 2004
105 Northern and southern Chinese populations 12 352 China 100 35–59 15.2 Incident stroke
CHD=coronary heart disease. CVD=cardiovascular disease.
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the varianceof the relative risks derivedfrom the odds
ratios,
1415 we performed a sensitivity analysis that
excluded four studies for which this transformation
had been applied. All analyses were performed with
Stata 10.0 (StataCorp, College Station TX, USA).
The Stata “metan” command was used to pool the
ln(relative risks) across studies according to the
DerSimonian and Laird random effects model.
16
In some studies, a single relative risk (or odds ratio)
was not available for drinkers versus non-drinkers
because the data were presented as only a dose-
response (that is, several alcohol consumption levels
relativetonon-drinkers).Inthesecases,wefirstpooled
across levels of intake within the study using a random
effectsmodeltoderiveasinglerelativeriskfordrinkers
versus non-drinkers. The resulting single, study-speci-
fic relative risk was then pooled with those of other
studies.
To visually assessthe relative risk estimatesand cor-
responding 95% confidence intervals across studies,
wegeneratedforestplotssortedbyyearofpublication.
Analyses were stratified by study quality criteria and
by participant characteristics.
To assess heterogeneity of relative risks across
studies,weinspectedforestplotsandcalculatedQ(sig-
nificance level of P≤0.10) and I
2 statistics.
1718 In the
presence of heterogeneity, random effects models
were used (rather than fixed effects models) to obtain
pooled effect estimates across studies. Sensitivity
analyses and stratified analyses were performed to
assess the associations of selected study quality and
clinical factors on cardiovascular risk, including num-
ber of confounding factors and duration of follow-up
dichotomisedat the median value.We also performed
a sensitivity analysis excluding studies reporting only
odds ratios. We conducteda cumulative meta-analysis
ofstudiesorderedchronologicallytoassessthesequen-
tial contributions of studies published over time.
19
Finally, we assessed evidence of publication bias
through visual inspection of funnel plots and Begg’s
rank correlation test for asymmetry.
2021
RESULTS
Identification of studies
Our initial search yielded a total of 4235 unique cita-
tions(fig 1).Aftertworoundsofreviewsandsearching
citations of retained articles, we identified 131 studies
as potentially relevant for analysis. We excluded stu-
dies of cardiovascular outcomes predefined as ineligi-
ble (such as chronic congestive heart failure or stable
angina), non-atherothrombotic end points (such as
arrhythmias), composite end points, or non-cardio-
vascular outcomes (such as cancer), and duplicate
reports. This left 84 studies for our systematic review
and meta-analysis. Table 1 provides details of the
included studies.
22-105 Of these 84 studies, 34 (40%)
reported on all-male cohorts, six (7%) reported on
women only, and 44 (52%) included both men and
women.
Study quality
We evaluated two primary features of study quality—
the number of years that participants were followed
and adjustment for confounding. Duration of follow-
up for study end points ranged from 2.5 to 35 years,
with a mean follow-up of 11 years (standard deviation
6years)(table 1).Oftheincludedstudies,13(15%)had
≤5 years of follow-up. Similarly, studies varied in the
degree of confounder adjustment, ranging from none
to 18 variables,with a mean of six (SD 4). Most studies
(68) presented adjusted estimates, but eight reported
only unadjusted estimates and another eight adjusted
only for basic demographic information. Methods of
adjustment,effectmeasure,andconfoundingvariables
used in each study are presented in the appendix
tables 1–5 on bmj.com for each of our primary
outcomes.
Primary analyses of cardiovascular disease mortality,
coronary heart disease incidence and mortality, and stroke
incidence and mortality
For cardiovascular disease mortality and both end
pointsforcoronaryheartdisease,alcoholconsumption
was associated with lower risk, with relative risks of
about 0.75 (table 2). In general, relative risks derived
from the more highly adjusted and from the less
adjusted results were similar. Figures 2–4 reveal little
visual evidence of heterogeneity despite statistical evi-
dence of heterogeneity (P<0.001, I
2=72.2%), probably
driven by the large number of participants (>1
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0.42 (0.24 to 0.73)
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0.79 (0.68 to 0.93)
0.71 (0.68 to 0.75)
0.79 (0.66 to 0.94)
0.49 (0.40 to 0.59)
0.81 (0.67 to 0.97)
0.80 (0.74 to 0.86)
0.47 (0.30 to 0.77)
0.60 (0.45 to 0.79)
0.74 (0.59 to 0.93)
0.54 (0.44 to 0.68)
0.86 (0.62 to 1.20)
1.07 (0.72 to 1.59)
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0.83 (0.78 to 0.89)
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Fig 2 | Forest plot of mortality from cardiovascular disease associated with alcohol
consumption
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BMJ | ONLINE FIRST | bmj.com page 5 of 13million). All the point estimates were <1.0 in studies,
exceptforonestudyforcardiovasculardiseasemortal-
ityandtwostudiesforcoronaryheartdiseaseincidence
and mortality.
Incontrast,theoverallassociationsofalcoholintake
with stroke incidence and mortality were close to null,
both in minimally adjusted and more highly adjusted
models (table 2, figs 5 and 6). However, this null asso-
ciation seemed to obscure nearly significant but oppo-
site associations with subtypes of incident stroke.
Among the 12 studies on incident haemorrhagic
stroke,thepooledrelativeriskforcurrentalcoholdrin-
kers compared with non-drinkers was 1.14 (95% con-
fidenceinterval0.97to1.34),whereastheeightstudies
on ischaemic stroke showed a moderate reduction in
the pooled relative risk of 0.92 (0.85 to 1.00). Alcohol
use was not associated with stroke mortality, but few
studies assessed the risk of mortality from
haemorrhagic or ischaemic stroke separately. Further-
more,onlytwostudiesreportedrelativerisksonstroke
end points for former drinkers compared with non-
drinkers.
Analyses of dose response
Analysesofthe doseof alcoholconsumedshowedthat
2.5–14.9galcohol(about≤1drink)perdaywasprotec-
tive for all five outcomes compared with no alcohol
(table 2). For coronary heart disease outcomes, all
levels of intake >2.5 g/day had similar degrees of risk
reduction.Forcardiovasculardisease mortalityas well
as stroke incidence and mortality, the dose-response
relations were less clear and more consistent with U
or J shaped curves, suggesting an increased risk
amongdrinkersof greateramounts ofalcohol. Specifi-
cally, those who consumed >60 g/day were at a signif-
icantlyincreasedriskofincidentstrokecomparedwith
abstainers (relative risk 1.62 (1.32 to 1.98)).
Sensitivity analyses
In ananalysisof differences in associations by sex,any
amount of alcohol consumption relative to none was
associatedwithgreaterreductionincardiovasculardis-
ease mortality, stroke incidence, and stroke mortality
for women than men. However, the association with
stroke should be interpreted with caution, as the risk
estimates for women are based on only three pooled
studies. On the other hand, similar associations by
sex were observed for coronary heart disease inci-
dence and mortality (table 2).
Sensitivity analyses that were confined to only stu-
dies that controlled for the important confounders of
smoking, age, and sex revealed generally similar
results for all of the outcomes. Additional sensitivity
analyses that account for the median number of con-
founding variables in the multivariable analyses of
included studies revealed that those with fewer (less
than the median) confounding variables generally
reported slightly lower relative risk estimates. How-
ever,thispatternwasinconsistentacrosstheoutcomes.
Specifically, an increased risk of stroke mortality was
observed for studies with limited adjustment for con-
founding. A similar trend was observed when consid-
ering the duration of follow-up. Using the pooled
median number of years as the cut point, we found
that studies with shorter follow-up reported a greater
risk reduction for all outcomes except cardiovascular
disease and coronary heart disease mortality (table 2).
Among those studies that used long term abstainers
as the referent category, excluding former drinkers or
evaluating them separately, the estimated association
between drinking and both incidence and mortality
estimates did not change substantively (table 2).
Among studies that evaluated former drinkers sepa-
rately, the risk of death (from cardiovascular disease
and coronary heart disease) was significantly higher
in former drinkers than in drinkers. However, former
drinkers did not have an increased risk of incident
cardiovascular events (coronary heart disease or
stroke).
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Fig 3 | Forest plot of incident coronary heart disease associated with alcohol consumption
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page 6 of 13 BMJ | ONLINE FIRST | bmj.comFinally, a sensitivity analysis that excluded the few
studies where only odds ratios instead of relative risks
were presented had little effect on the results. In cumu-
lative meta-analyses of cardiovascular disease and cor-
onary heart disease outcomes (appendix figs 1–3o n
bmj.com), there was little variation in the relative risk
associatedwithalcoholconsumptiononcardiovascular
disease mortality or incident coronary heart disease
with addition of new studies after 1999; for coronary
heart disease mortality, this plateau in incremental
change from new studies occurred as early as 1992–3.
Mortality from all causes
Of the 84 studies addressing alcohol and cardio-
vascular disease events, 31 also examined the associa-
tion of alcohol consumption with all cause mortality.
The pooled estimates from these studies showed a
lower risk of all causemortality for drinkerscompared
with non-drinkers (relative risk 0.87 (0.83 to 0.92))
(fig 7). However, the association was J shaped, with
the lowest risk for those consuming 2.5–14.9 g/day
(relative risk 0.83 (0.80 to 0.86), 16 studies) and an ele-
vated risk in those consuming >60 g/day (relative risk
1.30 (1.22 to 1.38), 8 studies).
Publication bias
Visual inspection of the funnel plot for each outcome
did not show asymmetry, an indication that significant
publication bias was not likely. This was further con-
firmed by a non-significant Begg’s test for each out-
come (for cardiovascular disease mortality, P=0.40;
incident coronary heart disease, P=0.75; coronary
heart disease mortality, P=0.089; incident stroke,
P=0.33; stroke mortality, P=0.59; all cause mortality,
P=0.26).
DISCUSSION
Inthisreviewof84studiesofalcoholconsumptionand
cardiovascular disease, alcohol consumption at 2.5–
14.9 g/day (about ≤1 drink a day) was consistently
associated with a 14–25% reduction in the risk of all
outcomes assessed compared with abstaining from
alcohol. Such a reduction in risk is potentially of clin-
icalimportance,butconsumptionoflargeramountsof
alcoholwasassociatedwithhigherrisksforstrokeinci-
dence and mortality.
To our knowledge, this systematic review and meta-
analysis is the most comprehensive to date. Although
roughly similar estimates of lower risk were observed
in previous meta-analyses of both coronary heart dis-
ease and stroke,
1-8 our review extends the findings by
assessing a broader array of relevant cardiovascular
outcomes and adding several new important studies.
Our review clarifies several discrepancies among
prior reports. Corrao et al reported a J shaped relation
between alcohol intake and coronary heart disease,
2
whereas the review by Maclure described this relation
as L shaped because he did not observe an increase in
coronaryheartdiseaseriskassociatedwithhigheralco-
hol consumption.
6 Our updated meta-analysis sup-
ports the latter association for coronary heart disease,
with a 25–35% risk reduction for light to moderate
drinking
106 that also is present with heavier drinking.
Our analysis of multiple cardiovascular outcomes
also shows the complexities inherent in the study of
alcohol consumption. Modestalcohol intakewasasso-
ciated with lower stroke incidence and mortality, but
the risk increased substantially with heavier drinking
(that is, a J shaped relation). Furthermore, the associa-
tion of alcohol consumption is complex and differs by
stroke subtype, with a slightly lower risk of ischaemic
stroke but higher risk of haemorrhagic stroke. These
differential associations probably reflect the known
antithromboticeffectsofalcohol.
107Alcoholconsump-
tion, particularly at high doses, also seems to have an
adverse association with blood pressure that may
account, in part, for the higher risk of haemorrhagic
stroke associated with heavier drinking.
108 Addition-
ally, our analysis does not consider other known detri-
mental effects of high alcohol consumption.
3
Therefore, our findings lend further support for limits
on alcohol consumption.
106109
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Fig 4 | Forest plot of mortality from coronary heart disease associated with alcohol
consumption
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 13Our review also highlights other important aspects
of the relation between alcohol consumption and
cardiovascular disease. Firstly, the lower risk of coron-
ary heart disease associated with alcohol consumption
was at least as strong for women as for men. Limited
evidencesuggeststhattheriskofstrokerelatedtoalco-
hol is lower for women than men, but this may only
reflect lower alcohol intake among women. Secondly,
inclusion of former drinkers did not seem to bias the
association of alcohol consumption with cardio-
vascular disease. Thirdly, when studies were sum-
marised chronologically, we found that the overall
association between drinking and cardiovascular dis-
ease and coronary heart disease became apparent at
leastadecadeago,andongoingstudieshavedonelittle
to revise the estimated associations.
An argument for causation
From the extensive body of literature summarised
here, the association between alcohol consumption
and decreased cardiovascular risk is not in question,
asadditionalresearchhasnotchangedthisconclusion.
Rather, the lingering question is whether this associa-
tion is causal. Clearly, observational studies cannot
establishcausation.However,whenthepresentresults
are coupled with those from our companion review
paper summarising interventional mechanistic studies
Table 2 |Stratified analyses of pooled relative risks (95% CI) for cardiovascular and stroke outcomes (number of pooled studies in parentheses after each
effect estimate)
Cardiovascular disease
mortality (n=21 studies,
1 184 956 subjects)
Coronary heart disease Stroke
Incident (n=29 studies,
549 504 subjects)
Mortality (n=31 studies,
1 925 106 subjects)
Incident (n=17 studies,
458 811 subjects)
Mortality (n=10 studies,
723 571 subjects)
Active drinkers v non-drinkers:
Least adjusted models 0.84 (0.75 to 0.95) (11) 0.73 (0.65 to 0.82) (14) 0.80 (0.70 to 0.91) (10) 1.01 (0.88 to 1.16) (10) 1.13 (0.96 to 1.32) (3)
Most adjusted models 0.75 (0.70 to 0.80) (21) 0.71 (0.66 to 0.77) (29) 0.75 (0.68 to 0.81) (31) 0.98 (0.91 to 1.06) (17) 1.06 (0.91 to 1.23) (10)
Active drinkers v lifetime abstainers 0.82 (0.78 to 0.86) (9) 0.73 (0.61 to 0.88) (9) 0.75 (0.66 to 0.85) (7) 0.93 (0.85 to 1.02) (7) 1.29 (1.09 to 1.53) (3)
Former drinkers v non-drinkers 1.48 (1.23 to1.79) (6) 1.10 (0.91 to 1.33) (8) 1.31 (1.02 to 1.68) (6) 0.87 (0.72 to 1.07) (4) Not reported (2)
Alcohol intake (g/day) v none:
<2.5 0.71 (0.57 to 0.89) (7) 0.96 (0.86 to 1.06) (6) 0.92 (0.80 to 1.06) (6) 0.81 (0.74 to 0.89) (3) 1.00 (0.75 to 1.34) (3)
2.5–14.9 0.77 (0.71 to 0.83) (15) 0.75 (0.65 to 0.88) (9) 0.79 (0.73 to 0.86) (18) 0.80 (0.74 to 0.87) (3) 0.86 (0.75 to 0.99) (6)
15–29.9 0.75 (0.70 to 0.80) (13) 0.66 (0.59 to 0.75) (15) 0.79 (0.71 to 0.88) (15) 0.92 (0.82 to 1.04) (5) 1.15 (0.86 to 1.54) (6)
30–60 0.85 (0.73 to 0.98) (10) 0.67 (0.56 to 0.79) (9) 0.77 (0.72 to 0.83) (12) 1.15 (0.98 to 1.35) (4) 1.10 (0.85 to 1.45) (5)
>60 0.99 (0.84 to 1.17) (6) 0.76 (0.52 to 1.09) (9) 0.75 (0.63 to 0.89) (9) 1.62 (1.32 to 1.98) (4) 1.44 (0.99 to 2.10) (3)
Sex:
Men 0.80 (0.73 to 0.87) (13) 0.71 (0.66 to 0.77) (25) 0.77 (0.72 to 0.82) (21) 1.02 (0.92 to 1.13) (11) 1.07 (0.89 to 1.28) (9)
Women 0.69 (0.60 to 0.78) (9) 0.71 (0.66 to 0.77) (11) 0.78 (0.64 to 0.94) (10) 0.87 (0.75 to 1.01) (4) 0.81 (0.67 to 0.98) (3)
Adjustmentforconfoundingfactors*:
Weak 0.74 (0.67 to 0.82) (10) 0.69 (0.62 to 0.76) (11) 0.72 (0.63 to 0.83) (15) 0.99 (0.86 to 1.13) (7) 1.30 (1.11 to 1.52) (5)
Strong 0.76 (0.70 to 0.83) (11) 0.72 (0.65 to 0.79) (18) 0.80 (0.75 to 0.86) (16) 0.99 (0.89 to 1.09) (10) 0.96 (0.81 to 1.14) (5)
Median follow-up time†:
Short 0.76 (0.71 to 0.83) (8) 0.71 (0.65 to 0.79) (14) 0.75 (0.67 to 0.85) (12) 0.98 (0.90 to 1.07) (9) 1.01 (0.82 to 1.24) (5)
Long 0.75 (0.67 to 0.84) (13) 0.72 (0.64 to 0.80) (15) 0.75 (0.67 to 0.84) (19) 1.00 (0.88 to 1.13) (8) 1.18 (1.02 to 1.37) (5)
*Adjustment for confounding factors was dichotomised as weak (<median value) or strong (≥median value). Cut points: ≥5 for coronary heart disease and stroke mortality, ≥6f o r
cardiovascular disease mortality and incident coronary heart disease, ≥7 for incident stroke.
†Total follow-up time was dichotomised as short (<median value) or long (≥median value). Cut points: ≥9 for incident coronary heart disease, ≥10 for cardiovascular disease mortality, ≥12
for coronary heart disease mortality and incident stroke, ≥14 for stroke mortality.
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Fig 5 | Forest plot of incident stroke associated with alcohol consumption
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disease,
110 the argument for causation becomes more
compelling.Indeed,themechanisticbiomarkerreview
showsbiologicalplausibilityforacausalassociationby
showing favourable changes in pathophysiologically
relevant molecules.
Therefore, we can now examine the argument for
causation based on Hill’s criteria.
111 Beyond the biolo-
gicalplausibilityargumentdiscussedabove,thereisan
appropriate temporal relation with alcohol use pre-
venting cardiovascular disease. Secondly, we have
observed a greater protective association with increas-
ing dose, except that it seems to be offset somewhat by
negative associations with the risk of haemorrhagic
stroke. Thirdly, the protective association of alcohol
has been consistently observed in diverse patient
populations and in both women and men. Fourthly,
the association is specific: moderate drinking (up to 1
drinkor12.5galcoholperdayforwomenand2drinks
or 25 g alcohol per day for men
106) is associated with
lower rates of cardiovascular disease but is not uni-
formly protective for other conditions, such as
cancer.
112 Lastly, the reduction in risk is notable even
when controlling for known confounders (such as
smoking, diet, and exercise). Any potential unmea-
sured confounder would need to be very strong to
explain away the apparently protective association.
Limitations of study
The results of our meta-analysis should be interpreted
in context of the limitations of available data. Firstly,
the quality of individual studies varied, with some stu-
dies having limited follow-up and limited adjustment
for potential confounding. With respect to study fol-
low-up, it is possible that misclassification of alcohol
consumption may increase with study length because
of changes in drinking habits over time. It is also pos-
sible that potential biological effects of alcohol vary
with time of exposure. However, arguing against
boththesepossibilities,theanalysisstratifiedbylength
of follow-up did not show different associations
between alcohol intake and outcome for shorter fol-
low-up times versus longer times.
Secondly, only a limited subset of studies provided
specific risk estimates for different beverages.
Although there is great interest in differences between
beer, wine, and spirits, alcoholic drinks generally have
similar effects on high density lipoprotein
cholesterol,
113anditislikelythatanyparticularbenefit
of wine is prone to confounding by diet and socioeco-
nomic status.
114115 None the less, this remains an inter-
esting topic for further investigation.
Thirdly, we found only limited information on the
relation between alcohol intake and mortality from
subtypes of stroke, so this topic continues to be impor-
tant for large observational cohort studies. Finally, we
observed significant heterogeneity across studies for
several of our pooled analyses. This may be due in
greatparttolargestudysamplesizes,whichcanconfer
greaterstatisticalpowertoheterogeneitytests,whereas
the clinical relevance of this heterogeneity may be
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Fig 6 | Forest plot of mortality from stroke associated with alcohol consumption
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Fig 7 | Forest plot of mortality from all causes associated with alcohol consumption
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10 Visual inspection of our various forest
plots and the relative consistency of pooled relative
risks across clinical and methodological variables sug-
gest that there is considerable consistency in the rela-
tive risk findings across studies and across strata.
Implications
Given the consistency observed in our findings and
compelling mechanistic data pointing to causation in
our companion review, additional observational stu-
dies will have limited value except to elucidate more
precisely the association of alcohol and stroke.
116
Rather, debate should centre now on how to integrate
this evidence into clinical practice and public health
messages.Intherealmofclinicalpractice,theevidence
could form a foundation for proposing counselling for
selected patients to incorporate moderate amounts of
alcoholintotheirdietstoimprovetheircoronaryheart
disease risk. However, such a clinical strategy requires
formalevaluationinpragmaticclinicaltrialsthatassess
the questionsof optimal patientselection, compliance,
risks, and benefits. The focus of such trials would shift
fromassessingtheassociationbetweenalcoholanddis-
ease outcomes to evaluating the receptivity of both
physicians and patients to the recommended con-
sumption of alcohol for therapeutic purposes and the
extent to which it can be successfully and safely imple-
mented. In support of implementation trials, our two
papers show that alcohol consumption in moderation
has reproducible and plausible effects on markers of
coronary heart disease risk.
With respect to public health messages, there may
nowbeanimpetustobettercommunicatetothepublic
that alcohol, in moderation, may have overall health
benefits that outweigh the risks in selected subsets of
patients. Again, any such strategy would need to be
accompanied by rigorous study and oversight of
impacts. One approach would be to undertake public
health messaging pilot studies on well defined target
populations (such as a workplace or in a small jurisdic-
tion) to permit detailed evaluation of effects on mea-
sures such as knowledge, attitudes, self reported
drinking behaviours, and perhaps, secondarily, health
outcomes.
The debate on how to integrate this evidence into
clinical practice and public health messages will
require integration of all possible effects of alcohol—
from injury and violence to glucose metabolism and
inflammation—and recognition that these effects may
be distributed unequally across the population. For
example, injury risk probably disproportionately
affects younger individuals, whereas cardiovascular
disease mainly affects older adults. Robust studies
that examine multiple outcomes simultaneously are
needed to identify those subsets of the population in
which reduced cardiovascular risk might dominate
against those for whom the risks of social and medical
problems (including several cancers and injury
112117)
are too great. Despite the latter concerns, results of
our secondary analysis of overall mortality (fig 5) sup-
port the notion that moderate alcohol consumption is
associatedwithnetbenefit,atleastinpopulationssimi-
lar to those studied in the extant literature.
Our two systematic review papers summarise a sur-
prisingly extensive body of literature on the relation
between alcohol and cardiovascular disease. Our find-
ingspointtotheneedtodefineimplicationsforclinical
and public health practice. These reviews and the per-
spectivesaboveprovideafoundationforthatdialogue.
Preliminary results from this manuscript were presented at the 32nd
annual meeting of the Society of General Internal Medicine, Miami,
Florida, 14 May 2009.
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